Novartis discontinues development of GT005 for geographic atrophy healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.
There is UK unemployment data on Tuesday, a US inflation print on Wednesday and the.
Syncona Ltd on Monday said it has been informed by Swiss-American pharmaceutical company Novartis AG that the development of eye treatment, GT005, for geographic atrophy secondary to dry age-related.
Purespring appoints Fredrik Erlandsson as Chief Medical Officer and Peter Mulcahy as Chief People Officer Appointments of Fredrik and Peter complete build-out of senior team London— 6 September 2023— Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, has appointed Fredrik Erlandson as Chief Medical Officer and Peter Mulcahy as Chief People Officer. These two key additional appointments complete Purespring’s leadership team, fillin